Localization of the forskolin labeling sites to both halves of P- glycoprotein: similarity of the sites labeled by forskolin and prazosin

DI Morris, LM Greenberger, EP Bruggemann, C Cardarelli, MM Gottesman, I Pastan and KB Seamon

Molecular Pharmacology Laboratory, Food and Drug Administration, Bethesda, Maryland 20892.

An iodinated derivative of forskolin, 6-O-[[2-[3-(4-azido-3-[125I] iodophenyl)propionamido]ethyl]carbamyl]forskolin ([125I]6-AIPP-Fsk), photolabels the multidrug efflux pump P-glycoprotein in membranes prepared from the multidrug-resistant cell lines KB-V1 and KB-C1. The labeling site for [125I]6-AIPP-Fsk was localized by immunoprecipitation of tryptic fragments of P-glycoprotein labeled in KB-C1 membranes. A 6- kDa, photolabeled, tryptic fragment was immunoprecipitated by antiserum raised against residues 348-419 of P-glycoprotein, PEPG9, but not by antisera raised against flanking regions PEPG7 and PEPG11. A peptide that corresponds to residues 343-359 of P-glycoprotein inhibited immunoprecipitation of the 6-kDa fragment by antiserum against PEPG9 but had no effect on the immunoprecipitation of photolabeled fragments by antiserum against PEPG7. A second peptide, corresponding to residues 360-376, had no effect on the immunoprecipitation by antiserum against PEPG9. [125I]6-AIPP-Fsk labels the carboxyl-terminal half of P- glycoprotein, because low molecular mass tryptic fragments were immunoprecipitated by three carboxyl-terminal antisera. Therefore, [125I]6-AIPP-Fsk labels both halves of P-glycoprotein, and labeling in the amino-terminal half can be localized to residues 291-359, which span proposed transmembrane regions 5 and 6. KB-V1 membranes photolabeled with [125I]6-AIPP-Fsk and [125I]iodoarylazidoprazosin were digested with either Staphylococcus aureus V8 protease or chymotrypsin and had similar digestion patterns, suggesting that the two drugs label the same sites on P-glycoprotein.

Volume 46, Issue 2, pp. 329-337, 08/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. F.K. Ejendal, N. K. Diop, L. C. Schweiger, and C. A. Hrycyna The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding. Protein Sci., July 1, 2006; 15(7): 1597 - 1607. [Abstract] [Full Text] [PDF]

				D. J. Gruol, M. N. King, and M. E. Kuehne Evidence for the Locations of Distinct Steroid and Vinca Alkaloid Interaction Domains within the Murine mdr1b P-Glycoprotein Mol. Pharmacol., November 1, 2002; 62(5): 1238 - 1248. [Abstract] [Full Text] [PDF]

				C. Borchers, R. Boer, K. Klemm, V. Figala, T. Denzinger, W.-R. Ulrich, S. Haas, W. Ise, V. Gekeler, and M. Przybylski Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry Mol. Pharmacol., June 1, 2002; 61(6): 1366 - 1376. [Abstract] [Full Text] [PDF]

				J. M. Falcon-Perez, M. Martinez-Burgos, J. Molano, M. J. Mazon, and P. Eraso Domain Interactions in the Yeast ATP Binding Cassette Transporter Ycf1p: Intragenic Suppressor Analysis of Mutations in the Nucleotide Binding Domains J. Bacteriol., August 15, 2001; 183(16): 4761 - 4770. [Abstract] [Full Text] [PDF]

				D. J. Gruol, J. Bernd, A. E. Phippard, I. Ojima, and R. J. Bernacki The Use of a Novel Taxane-Based P-Glycoprotein Inhibitor to Identify Mutations That Alter the Interaction of the Protein with Paclitaxel Mol. Pharmacol., July 1, 2001; 60(1): 104 - 113. [Abstract] [Full Text]

				M. Putman, H. W. van Veen, and W. N. Konings Molecular Properties of Bacterial Multidrug Transporters Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 672 - 693. [Abstract] [Full Text] [PDF]

				C. Martin, G. Berridge, C. F. Higgins, P. Mistry, P. Charlton, and R. Callaghan Communication between Multiple Drug Binding Sites on P-glycoprotein Mol. Pharmacol., September 1, 2000; 58(3): 624 - 632. [Abstract] [Full Text]

				Z. E. Sauna and S. V. Ambudkar Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein PNAS, March 14, 2000; 97(6): 2515 - 2520. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke The Packing of the Transmembrane Segments of Human Multidrug Resistance P-glycoprotein Is Revealed by Disulfide Cross-linking Analysis J. Biol. Chem., February 25, 2000; 275(8): 5253 - 5256. [Abstract] [Full Text] [PDF]

				Y. Zhou, M. M. Gottesman, and I. Pastan Domain Exchangeability between the Multidrug Transporter (MDR1) and Phosphatidylcholine Flippase (MDR2) Mol. Pharmacol., November 1, 1999; 56(5): 997 - 1004. [Abstract] [Full Text]

				T. W. Loo and D. M. Clarke The Transmembrane Domains of the Human Multidrug Resistance P-glycoprotein Are Sufficient to Mediate Drug Binding and Trafficking to the Cell Surface J. Biol. Chem., August 27, 1999; 274(35): 24759 - 24765. [Abstract] [Full Text] [PDF]

				Q. D. Vo and D. J. Gruol Identification of P-glycoprotein Mutations Causing a Loss of Steroid Recognition and Transport J. Biol. Chem., July 16, 1999; 274(29): 20318 - 20327. [Abstract] [Full Text] [PDF]

				Y. Zhou, M. M. Gottesman, and I. Pastan Studies of Human MDR1-MDR2 Chimeras Demonstrate the Functional Exchangeability of a Major Transmembrane Segment of the Multidrug Transporter and Phosphatidylcholine Flippase Mol. Cell. Biol., February 1, 1999; 19(2): 1450 - 1459. [Abstract] [Full Text] [PDF]

				T. Shoshani, S. Zhang, S. Dey, I. Pastan, and M. M. Gottesman Analysis of Random Recombination between Human MDR1 and Mouse Mdr1a cDNA in a pHaMDR-Dihydrofolate Reductase Bicistronic Expression System Mol. Pharmacol., October 1, 1998; 54(4): 623 - 630. [Abstract] [Full Text]

				T. W. Loo and D. M. Clarke Superfolding of the Partially Unfolded Core-glycosylated Intermediate of Human P-glycoprotein into the Mature Enzyme Is Promoted by Substrate-induced Transmembrane Domain Interactions J. Biol. Chem., June 12, 1998; 273(24): 14671 - 14674. [Abstract] [Full Text] [PDF]

				G. Merino and H. A. Shuman Truncation of MalF Results in Lactose Transport via the Maltose Transport System of Escherichia coli J. Biol. Chem., January 23, 1998; 273(4): 2435 - 2444. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate J. Biol. Chem., December 19, 1997; 272(51): 31945 - 31948. [Abstract] [Full Text] [PDF]

				S. Dey, M. Ramachandra, I. Pastan, M. M. Gottesman, and S. V. Ambudkar Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein PNAS, September 30, 1997; 94(20): 10594 - 10599. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Drug-stimulated ATPase Activity of Human P-glycoprotein Requires Movement between Transmembrane Segments 6 and 12 J. Biol. Chem., August 22, 1997; 272(34): 20986 - 20989. [Abstract] [Full Text] [PDF]

				A. Demmer, H. Thole, P. Kubesch, T. Brandt, M. Raida, R. Fislage, and B. Tummler Localization of the Iodomycin Binding Site in Hamster P-glycoprotein J. Biol. Chem., August 15, 1997; 272(33): 20913 - 20919. [Abstract] [Full Text] [PDF]

				J. F. Ma, G. Grant, and P. W. Melera Mutations in the Sixth Transmembrane Domain of P-Glycoprotein that Alter the Pattern of Cross-resistance Also Alter Sensitivity to Cyclosporin A Reversal Mol. Pharmacol., June 1, 1997; 51(6): 922 - 930. [Abstract] [Full Text]

				T. W. Loo and D. M. Clarke Inhibition of Oxidative Cross-linking between Engineered Cysteine Residues at Positions 332in Predicted Transmembrane Segments (TM) 6and 975in Predicted TM12 of Human P-glycoprotein by Drug Substrates J. Biol. Chem., November 1, 1996; 271(44): 27482 - 27487. [Abstract] [Full Text] [PDF]

				W. Tang and A. Gilman Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin Science, June 23, 1995; 268(5218): 1769 - 1772. [Abstract] [PDF]

				X. Zhang, K. I. Collins, and L. M. Greenberger Functional Evidence That Transmembrane 12 and the Loop between Transmembrane 11 and 12 Form Part of the Drug-binding Domain in P-glycoprotein Encoded by MDR1 J. Biol. Chem., March 10, 1995; 270(10): 5441 - 5448. [Abstract] [Full Text] [PDF]

				M.M. Gottesman, S.V. Ambudkar, B. Ni, J.M. Aran, Y. Sugimoto, C.O. Cardarelli, and I. Pastan Exploiting Multidrug Resistance to Treat Cancer Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 677 - 683. [Abstract] [PDF]

				T. W. Loo and D. M. Clarke Determining the Dimensions of the Drug-binding Domain of Human P-glycoprotein Using Thiol Cross-linking Compounds as Molecular Rulers J. Biol. Chem., September 28, 2001; 276(40): 36877 - 36880. [Abstract] [Full Text] [PDF]

				S. Ryu, T. Kawabe, S. Nada, and A. Yamaguchi Identification of Basic Residues Involved in Drug Export Function of Human Multidrug Resistance-associated Protein 2 J. Biol. Chem., December 8, 2000; 275(50): 39617 - 39624. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane J. Biol. Chem., December 8, 2000; 275(50): 39272 - 39278. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil J. Biol. Chem., April 27, 2001; 276(18): 14972 - 14979. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Cross-linking of Human Multidrug Resistance P-glycoprotein by the Substrate, Tris-(2-maleimidoethyl)amine, Is Altered by ATP Hydrolysis. EVIDENCE FOR ROTATION OF A TRANSMEMBRANE HELIX J. Biol. Chem., August 17, 2001; 276(34): 31800 - 31805. [Abstract] [Full Text] [PDF]